NovoRapid (insulin aspart), a new rapid-acting insulin analog

Novo Nordisk is now marketing NovoRapid (insulin aspart), a new rapid-acting insulin analog.

It's available in the U.S. under the brand name Novolog.

NovoRapid is similar to Humalog (insulin lispro).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote